Global Production & Supply Chain Resilience
Qualified manufacturing relationships, strategic collaborations and proposed joint ventures configured for capability, quality and regional access.

Global health innovation group
Connecting science, products and markets through a growing portfolio of health businesses.
GBM / 01
Specialist companies working across diagnostics, research, consumer health and pathways to market.
Diagnostics & Commercialization
Diagnostic technologies, qualified manufacturing pathways and product commercialization.
Research, IP & Technology Translation
Research programs, intellectual property and the translation of promising science into real-world applications.
Consumer Health & Market Access
Consumer health brands, cross-border development and localized pathways to market.
Global pathways
Research, qualified production, regulatory pathways and market execution are connected around each opportunity.
Explore global reachQualified manufacturing relationships, strategic collaborations and proposed joint ventures configured for capability, quality and regional access.
B2B, B2G, B2B2C and direct-to-consumer pathways connected through digital commerce, distribution and localized execution.
Milestones & Recognition
Research collaborations, market pathways and leadership recognition presented through full stories, clear status and official sources.

EY Canada named Jessica Hu of GBM Health Holding Ltd. an EY Entrepreneur Of The Year® 2026 Pacific finalist in the Science and Technology category. For GBM, the recognition marks an important stage in the company’s evolution from an operating diagnostics business into a growing health platform connecting research, commercialization and international market access.
Read the story
Geno10X Biosciences, Gene Bio Medical and Simon Fraser University researchers are collaborating on an R&D program exploring a point-of-care platform that combines sensitive HPV urine testing with AI-supported risk assessment. Innovate BC awarded C$300,000 to the collaboration, while a separate C$225,000 NSERC Alliance project supports related SFU-led sensor research.
Read the story
Gene Bio Medical and Bidiphar signed a memorandum of understanding to explore a diagnostics joint venture in Vietnam. The relationship developed after a Team Canada Trade Mission supported by the Trade Commissioner Service and CanExport SMEs. The MOU represents a strategic pathway—not evidence that GBM currently operates a factory or completed joint venture in Vietnam.
Read the story
From February 3 to 11, 2026, Jessica Hu represented GBM Health Group on the Asia Pacific Foundation of Canada’s Canadian Women-only Business Mission to the Philippines and Singapore. The program combined B2B matchmaking, company presentations, institutional visits and networking, concluding in Singapore alongside CIAC2026 and CanWIN’s investor forum.
Read the story
Jessica Hu was included in the EY Entrepreneurial Winning Women™ North America Class of 2025. EY’s official page lists her with Gene Biotechnology Enterprises Ltd. and profiles Gene Bio Medical’s work in molecular diagnostics, research, manufacturing and commercialization.
Read the storyPartner & Invest
Connect with GBM across research, commercialization, market access, investment or media.
Start a conversation
Founder & CEO
A biopharmaceutical engineer and entrepreneur building an integrated platform across diagnostics, research and global commercialization.